SLC7A11 and cancer: Moreover, BAP1 partially prevents the progression of tumors via SLC7A11 as well as ferroptosis, and cancer-related BAP1 mutants end up losing their capacities to suppress SLC7A11 and to stimulate ferroptosis [25].